Sepsis is a critical condition characterized by increased levels of pro-inflammatory cytokines
and proliferating cells such as neutrophils and macrophages in response to microbial …

Sepsis is a clinical syndrome defined as a dysregulated host response to infection resulting
in life-threatening organ dysfunction. Sepsis is a major public health concern associated …

Sepsis is resulted from a systemic inflammatory response to bacterial, viral, or fungal agents.
The induced inflammatory response by these microorganisms can lead to multiple organ …

Platelets, key facilitators of primary hemostasis and thrombosis, have emerged as crucial
cellular mediators of innate immunity and inflammation. Exemplified by their ability to alter …

Extracellular vesicle‐bound DNA (evDNA) is an understudied extracellular vesicle (EV)
cargo, particularly in cancer‐unrelated research. Although evDNA has been detected in …

In the process of sepsis, activated platelets shed microvesicles containing microRNAs
(miRNAs), which can be internalized by distinct recipient cells in circulation, consequently …

Sepsis has affected millions of populations of all age groups, locations, and sexes
worldwide. Immune systems, either innate or adaptive are dysregulated due to the infection …

This study was designed to evaluate antiplatelet effect and therapeutic effect of ginkgo
diterpene lactone meglumine injection (GDLI) in acute ischemic stroke (AIS) patients. In this …

Sepsis is a dysregulated immune response disease affecting millions worldwide. Delayed
diagnosis, poor prognosis, and disease heterogeneity make its treatment ineffective …

During sepsis, an initial prothrombotic shift takes place, in which coagulatory acute-phase
proteins are increased, while anticoagulatory factors and platelet count decrease. Further …